F-group (family)
5001.1.1.3 7tm_2
Ligands and drugs
560
Member domains
111
with ligand contacts (≤ 4 Å)
19.8% of members
93
with DrugDomain annotations
16.6% of members
50
with a DrugBank compound
8.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5001.1.1.3 belongs to X-group 5001 Family A G protein-coupled receptor-like, which binds 10.2 ligand superclasses per 20 proteins, broader than 95% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 22 |
| DB04540 | CLR | Cholesterol | 22 |
| DB16043 | UK4 | PF-06882961 | 4 |
| DB01708 | AND | Prasterone | 3 |
| DB14946 | KHF | PCO-371 | 2 |
| DB18964 | V6G | Orforglipron | 2 |
| DB00142 | GGL | Glutamic acid | 1 |
| DB00741 | HCY | Hydrocortisone | 1 |
| DB01278 | — | — | 1 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 1 |
| DB08558 | SOG | 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
| DB12044 | 5MV | MK-0893 | 1 |
| DB12457 | — | — | 1 |
| DB12637 | — | — | 1 |
| DB13928 | — | — | 1 |
| DB14027 | — | — | 1 |
| DB15328 | — | — | 1 |
| DB15688 | — | — | 1 |
| DB16098 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 23 |
| PLM | PALMITIC ACID | 23 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 14 |
| OLA | OLEIC ACID | 10 |
| 97Y | N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine | 8 |
| D6M | N-hexadecanoyl-L-glutamic acid | 8 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 8 |
| P42 | (2S)-2-{[(1R)-1-hydroxyhexadecyl]oxy}-3-{[(1R)-1-hydroxyoctadecyl]oxy}propyl 2-(trimethylammonio)ethyl phosphate | 8 |
| 1Q5 | 3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine | 6 |
| 97V | 4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide | 6 |
| DHT | 5-ALPHA-DIHYDROTESTOSTERONE | 6 |
| A1B90 | icosanedioic acid | 5 |
| AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | 4 |
| HNO | N-tert-butyl-6,7-bis(chloranyl)quinoxalin-2-amine | 4 |
| UK4 | 2-[(4-{6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2S)-oxetan-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid | 4 |
| K6G | [(2~{R})-2-oxidanyl-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] hexadecanoate | 3 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 3 |
| A1LU1 | Metenolone | 2 |
| KHF | PCO-371 | 2 |
| PIO | [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | 2 |